Are Wrinkle Treatments With AHAs, BHAs OTCs? FDA Issues Call For Data

FDA is requesting information on the possible physiological effects of alpha hydroxy and beta hydroxy acids in wrinkle removers to help evaluate their regulatory status, according to a Dec. 31 Federal Register notice

More from Archive

More from HBW Insight